AbbVie has substantially cut the price of its newly approved hepatitis C drug to win an exclusive deal with Express Scripts, the nation's largest manager of prescription drug benefits, the companies said Monday.
Similar Stories to Abbvie Lowers Price Of Hepatitis C Drug To Win Deal With Express Scripts on Bing News
Ellen Jean Hirst, Chicago Tribune
Mon, 12/22/2014 - 12:15pm
BING NEWS:
- AbbVie Gets Full OK For Cancer Drug Acquired in ImmunoGen Deal
AbbVie said the Food and Drug Administration had fully approved its ovarian cancer treatment, which was acquired in its recently closed purchase of biotech company ImmunoGen. The drug company ...
03/22/2024 - 8:25 am | View Link - AbbVie inks $713m deal for OSE chronic inflammation drug
AbbVie has made another bolt-on deal in the immunology and inflammation ... Frontiers in Immunology journal last year showed that the drug was able to reprogramme macrophages to reduce ...
02/27/2024 - 11:00 am | View Link - Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
Biotech stocks rose as AbbVie announced plans to buy cancer drug ... of the deal, AbbVie will pay $31.26 a share in cash for ImmunoGen, a roughly 95% premium to Wednesday's closing price.
11/30/2023 - 4:30 am | View Link - More
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more